Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 176

    1.

    Learned meal initiation attenuates the anorexic effects of the melanocortin agonist MTII.

    Benoit SC, Clegg DJ, Barrera JG, Seeley RJ, Woods SC.

    Diabetes. 2003 Nov;52(11):2684-8.PMID: 14578286 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Increased dietary fat attenuates the anorexic effects of intracerebroventricular injections of MTII.

    Clegg DJ, Benoit SC, Air EL, Jackman A, Tso P, D'Alessio D, Woods SC, Seeley RJ.

    Endocrinology. 2003 Jul;144(7):2941-6.PMID: 12810549 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Central melanocortin receptor agonist reduces spontaneous and scheduled meal size but does not augment duodenal preload-induced feeding inhibition.

    Azzara AV, Sokolnicki JP, Schwartz GJ.

    Physiol Behav. 2002 Nov;77(2-3):411-6.PMID: 12419417 [PubMed - indexed for MEDLINE]Related articles

    4.

    Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion.

    Thiele TE, van Dijk G, Yagaloff KA, Fisher SL, Schwartz M, Burn P, Seeley RJ.

    Am J Physiol. 1998 Jan;274(1 Pt 2):R248-54.PMID: 9458925 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Behavioral processes underlying the intake suppressive effects of melanocortin 3/4 receptor activation in the rat.

    Williams DL, Grill HJ, Weiss SM, Baird JP, Kaplan JM.

    Psychopharmacology (Berl). 2002 Apr;161(1):47-53. Epub 2002 Mar 1.PMID: 11967630 [PubMed - indexed for MEDLINE]Related articles

    6.

    Feeding response to melanocortin agonist predicts preference for and obesity from a high-fat diet.

    Chandler PC, Viana JB, Oswald KD, Wauford PK, Boggiano MM.

    Physiol Behav. 2005 Jun 2;85(2):221-30.PMID: 15893778 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity.

    Pierroz DD, Ziotopoulou M, Ungsunan L, Moschos S, Flier JS, Mantzoros CS.

    Diabetes. 2002 May;51(5):1337-45.PMID: 11978628 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Aged-obese rats exhibit robust responses to a melanocortin agonist and antagonist despite leptin resistance.

    Zhang Y, Matheny M, Tümer N, Scarpace PJ.

    Neurobiol Aging. 2004 Nov-Dec;25(10):1349-60.PMID: 15465633 [PubMed - indexed for MEDLINE]Related articles

    9.
    10.

    Decrease of food intake by MC4-R agonist MTII in Siberian hamsters in long and short photoperiods.

    Schuhler S, Horan TL, Hastings MH, Mercer JG, Morgan PJ, Ebling FJ.

    Am J Physiol Regul Integr Comp Physiol. 2003 Jan;284(1):R227-32. Epub 2002 Sep 27.PMID: 12388479 [PubMed - indexed for MEDLINE]Related articles

    11.

    Anorexic but not pyrogenic actions of interleukin-1 are modulated by central melanocortin-3/4 receptors in the rat.

    Lawrence CB, Rothwell NJ.

    J Neuroendocrinol. 2001 Jun;13(6):490-5.PMID: 11412335 [PubMed - indexed for MEDLINE]Related articles

    12.

    Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats.

    Hwa JJ, Ghibaudi L, Gao J, Parker EM.

    Am J Physiol Regul Integr Comp Physiol. 2001 Aug;281(2):R444-51.PMID: 11448846 [PubMed - indexed for MEDLINE]Related articles

    13.

    Melanocortin mediated inhibition of feeding behavior in rats.

    Murphy B, Nunes CN, Ronan JJ, Harper CM, Beall MJ, Hanaway M, Fairhurst AM, Van der Ploeg LH, MacIntyre DE, Mellin TN.

    Neuropeptides. 1998 Dec;32(6):491-7.PMID: 9920446 [PubMed - indexed for MEDLINE]Related articles

    14.

    Feeding responses to a melanocortin agonist and antagonist in obesity induced by a palatable high-fat diet.

    Hansen MJ, Schiöth HB, Morris MJ.

    Brain Res. 2005 Mar 28;1039(1-2):137-45.PMID: 15781055 [PubMed - indexed for MEDLINE]Related articles

    15.

    The effect of the melanocortin agonist, MT-II, on the defended level of body adiposity.

    Seeley RJ, Burklow ML, Wilmer KA, Matthews CC, Reizes O, McOsker CC, Trokhan DP, Gross MC, Sheldon RJ.

    Endocrinology. 2005 Sep;146(9):3732-8. Epub 2005 Jun 2.PMID: 15932932 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Leptin-like effects of MTII are augmented in MSG-obese rats.

    Kim YW, Choi DW, Park YH, Huh JY, Won KC, Choi KH, Park SY, Kim JY, Lee SK.

    Regul Pept. 2005 Apr 15;127(1-3):63-70.PMID: 15680471 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of i.c.v. infusion of the alpha-MSH agonist MTII on meal patterns in male rats following nicotine withdrawal.

    Bellinger L, Cepeda-Benito A, Bullard RL, Wellman PJ.

    Life Sci. 2003 Aug 22;73(14):1861-72.PMID: 12888124 [PubMed - indexed for MEDLINE]Related articles

    18.

    The hypothalamic paraventricular nucleus is not essential for orexigenic NPY or anorexigenic melanocortin action.

    Dube MG, Kalra SP, Kalra PS.

    Peptides. 2006 Sep;27(9):2239-48. Epub 2006 Jun 8.PMID: 16759748 [PubMed - indexed for MEDLINE]Related articles

    19.

    Melanocortinergic modulation of cholecystokinin-induced suppression of feeding through extracellular signal-regulated kinase signaling in rat solitary nucleus.

    Sutton GM, Duos B, Patterson LM, Berthoud HR.

    Endocrinology. 2005 Sep;146(9):3739-47. Epub 2005 Jun 16.PMID: 15961554 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Melanocortin receptor agonist transiently increases oxygen consumption in rats.

    Jonsson L, Skarphedinsson JO, Skuladottir GV, Atlason PT, Eiriksdottir VH, Franzson L, Schiöth HB.

    Neuroreport. 2001 Dec 4;12(17):3703-8.PMID: 11726778 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data